PARIS--(BUSINESS WIRE)--Regulatory News: OSE Pharma SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE), an immuno-oncology company developing a T-specific immunotherapy, currently in a registration Phase ...

The "Contract Manufacturing in Pharmaceutical Industry, 2015 - 2025" report provides an extensive study of the rapidly growing pharmaceutical contract manufacturing market. With pharmaceutical and ...

"GAAP net income attributable to Biogen Inc." CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Inc. (NASDAQ: BIIB) today reported full year and fourth quarter 2015 results, including full year revenues of ...

Editor’s Note: Researchers have recently uncovered the “immortality gene” which could unlock biological immortality in humans. And the profit opportunity for the top pharmaceutical companies in this ...

The number of mergers and acquisitions in the health IT and pharmaceutical information spaces continues to grow. In 2015, there were 446 M&A transactions in health IT and pharmaceuticals, reaching a ...

As the drumbeat for drug pricing reform has grown, two things are becoming clear: This issue is not going away, and Pharma’s time-worn rebuttals are increasingly unlikely to save the industry from ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "The Corporate Reputation of Pharma 2015 - The Perspective of 111 Patient Groups with an Interest in Hepatitis" report ...

Forbes contributors publish independent expert analyses and insights. I like biomedical innovation. And data. Not necessarily in that order. Many pharma critics argue that drug companies skimp on ...

* Main objectives for 2016 are recruiting first patients in clinical trials with Lymfactin and CDNF * Year ago objective has been set to enter commercialization agreement for at least one of top ...

The pharmaceutical industry leverages Washington’s culture of corruption to increase profits while everyday Americans suffer from high drug prices. With President Donald Trump looking on, U.S.